Anti-Tumor Drugs Market - Global Outlook and Forecast 2021-2027

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Anti-Tumor Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Anti-Tumor Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Anti-Tumor Drugs Overall Market Size
2.1 Global Anti-Tumor Drugs Market Size: 2021 VS 2027
2.2 Global Anti-Tumor Drugs Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Anti-Tumor Drugs Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Anti-Tumor Drugs Players in Global Market
3.2 Top Global Anti-Tumor Drugs Companies Ranked by Revenue
3.3 Global Anti-Tumor Drugs Revenue by Companies
3.4 Global Anti-Tumor Drugs Sales by Companies
3.5 Global Anti-Tumor Drugs Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Anti-Tumor Drugs Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Anti-Tumor Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Anti-Tumor Drugs Players in Global Market
3.8.1 List of Global Tier 1 Anti-Tumor Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Anti-Tumor Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Anti-Tumor Drugs Market Size Markets, 2021 & 2027
4.1.2 Surgical
4.1.3 Chemotherapy
4.1.4 Radiation
4.1.5 Targeted
4.1.6 Immunotherapy
4.2 By Type - Global Anti-Tumor Drugs Revenue & Forecasts
4.2.1 By Type - Global Anti-Tumor Drugs Revenue, 2016-2021
4.2.2 By Type - Global Anti-Tumor Drugs Revenue, 2022-2027
4.2.3 By Type - Global Anti-Tumor Drugs Revenue Market Share, 2016-2027
4.3 By Type - Global Anti-Tumor Drugs Sales & Forecasts
4.3.1 By Type - Global Anti-Tumor Drugs Sales, 2016-2021
4.3.2 By Type - Global Anti-Tumor Drugs Sales, 2022-2027
4.3.3 By Type - Global Anti-Tumor Drugs Sales Market Share, 2016-2027
4.4 By Type - Global Anti-Tumor Drugs Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Anti-Tumor Drugs Market Size, 2021 & 2027
5.1.2 Hospital Use
5.1.3 Clinic Use
5.1.4 Household
5.1.5 Other
5.2 By Application - Global Anti-Tumor Drugs Revenue & Forecasts
5.2.1 By Application - Global Anti-Tumor Drugs Revenue, 2016-2021
5.2.2 By Application - Global Anti-Tumor Drugs Revenue, 2022-2027
5.2.3 By Application - Global Anti-Tumor Drugs Revenue Market Share, 2016-2027
5.3 By Application - Global Anti-Tumor Drugs Sales & Forecasts
5.3.1 By Application - Global Anti-Tumor Drugs Sales, 2016-2021
5.3.2 By Application - Global Anti-Tumor Drugs Sales, 2022-2027
5.3.3 By Application - Global Anti-Tumor Drugs Sales Market Share, 2016-2027
5.4 By Application - Global Anti-Tumor Drugs Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Anti-Tumor Drugs Market Size, 2021 & 2027
6.2 By Region - Global Anti-Tumor Drugs Revenue & Forecasts
6.2.1 By Region - Global Anti-Tumor Drugs Revenue, 2016-2021
6.2.2 By Region - Global Anti-Tumor Drugs Revenue, 2022-2027
6.2.3 By Region - Global Anti-Tumor Drugs Revenue Market Share, 2016-2027
6.3 By Region - Global Anti-Tumor Drugs Sales & Forecasts
6.3.1 By Region - Global Anti-Tumor Drugs Sales, 2016-2021
6.3.2 By Region - Global Anti-Tumor Drugs Sales, 2022-2027
6.3.3 By Region - Global Anti-Tumor Drugs Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Anti-Tumor Drugs Revenue, 2016-2027
6.4.2 By Country - North America Anti-Tumor Drugs Sales, 2016-2027
6.4.3 US Anti-Tumor Drugs Market Size, 2016-2027
6.4.4 Canada Anti-Tumor Drugs Market Size, 2016-2027
6.4.5 Mexico Anti-Tumor Drugs Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Anti-Tumor Drugs Revenue, 2016-2027
6.5.2 By Country - Europe Anti-Tumor Drugs Sales, 2016-2027
6.5.3 Germany Anti-Tumor Drugs Market Size, 2016-2027
6.5.4 France Anti-Tumor Drugs Market Size, 2016-2027
6.5.5 U.K. Anti-Tumor Drugs Market Size, 2016-2027
6.5.6 Italy Anti-Tumor Drugs Market Size, 2016-2027
6.5.7 Russia Anti-Tumor Drugs Market Size, 2016-2027
6.5.8 Nordic Countries Anti-Tumor Drugs Market Size, 2016-2027
6.5.9 Benelux Anti-Tumor Drugs Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Anti-Tumor Drugs Revenue, 2016-2027
6.6.2 By Region - Asia Anti-Tumor Drugs Sales, 2016-2027
6.6.3 China Anti-Tumor Drugs Market Size, 2016-2027
6.6.4 Japan Anti-Tumor Drugs Market Size, 2016-2027
6.6.5 South Korea Anti-Tumor Drugs Market Size, 2016-2027
6.6.6 Southeast Asia Anti-Tumor Drugs Market Size, 2016-2027
6.6.7 India Anti-Tumor Drugs Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Anti-Tumor Drugs Revenue, 2016-2027
6.7.2 By Country - South America Anti-Tumor Drugs Sales, 2016-2027
6.7.3 Brazil Anti-Tumor Drugs Market Size, 2016-2027
6.7.4 Argentina Anti-Tumor Drugs Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Anti-Tumor Drugs Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Anti-Tumor Drugs Sales, 2016-2027
6.8.3 Turkey Anti-Tumor Drugs Market Size, 2016-2027
6.8.4 Israel Anti-Tumor Drugs Market Size, 2016-2027
6.8.5 Saudi Arabia Anti-Tumor Drugs Market Size, 2016-2027
6.8.6 UAE Anti-Tumor Drugs Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 Roche
7.1.1 Roche Corporate Summary
7.1.2 Roche Business Overview
7.1.3 Roche Anti-Tumor Drugs Major Product Offerings
7.1.4 Roche Anti-Tumor Drugs Sales and Revenue in Global (2016-2021)
7.1.5 Roche Key News
7.2 Novartis
7.2.1 Novartis Corporate Summary
7.2.2 Novartis Business Overview
7.2.3 Novartis Anti-Tumor Drugs Major Product Offerings
7.2.4 Novartis Anti-Tumor Drugs Sales and Revenue in Global (2016-2021)
7.2.5 Novartis Key News
7.3 Celgene
7.3.1 Celgene Corporate Summary
7.3.2 Celgene Business Overview
7.3.3 Celgene Anti-Tumor Drugs Major Product Offerings
7.3.4 Celgene Anti-Tumor Drugs Sales and Revenue in Global (2016-2021)
7.3.5 Celgene Key News
8 Global Anti-Tumor Drugs Production Capacity, Analysis
8.1 Global Anti-Tumor Drugs Production Capacity, 2016-2027
8.2 Anti-Tumor Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Anti-Tumor Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Anti-Tumor Drugs Supply Chain Analysis
10.1 Anti-Tumor Drugs Industry Value Chain
10.2 Anti-Tumor Drugs Upstream Market
10.3 Anti-Tumor Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Anti-Tumor Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer


List of Tables
Table 1. Key Players of Anti-Tumor Drugs in Global Market
Table 2. Top Anti-Tumor Drugs Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Anti-Tumor Drugs Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Anti-Tumor Drugs Revenue Share by Companies, 2016-2021
Table 5. Global Anti-Tumor Drugs Sales by Companies, (K Units), 2016-2021
Table 6. Global Anti-Tumor Drugs Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Anti-Tumor Drugs Price (2016-2021) & (USD/Unit)
Table 8. Global Manufacturers Anti-Tumor Drugs Product Type
Table 9. List of Global Tier 1 Anti-Tumor Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Anti-Tumor Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - Global Anti-Tumor Drugs Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Global Anti-Tumor Drugs Revenue (US$, Mn), 2016-2021
Table 13. By Type - Global Anti-Tumor Drugs Revenue (US$, Mn), 2022-2027
Table 14. By Type - Global Anti-Tumor Drugs Sales (K Units), 2016-2021
Table 15. By Type - Global Anti-Tumor Drugs Sales (K Units), 2022-2027
Table 16. By Application - Global Anti-Tumor Drugs Revenue, (US$, Mn), 2021 VS 2027
Table 17. By Application - Global Anti-Tumor Drugs Revenue (US$, Mn), 2016-2021
Table 18. By Application - Global Anti-Tumor Drugs Revenue (US$, Mn), 2022-2027
Table 19. By Application - Global Anti-Tumor Drugs Sales (K Units), 2016-2021
Table 20. By Application - Global Anti-Tumor Drugs Sales (K Units), 2022-2027
Table 21. By Region - Global Anti-Tumor Drugs Revenue, (US$, Mn), 2021 VS 2027
Table 22. By Region - Global Anti-Tumor Drugs Revenue (US$, Mn), 2016-2021
Table 23. By Region - Global Anti-Tumor Drugs Revenue (US$, Mn), 2022-2027
Table 24. By Region - Global Anti-Tumor Drugs Sales (K Units), 2016-2021
Table 25. By Region - Global Anti-Tumor Drugs Sales (K Units), 2022-2027
Table 26. By Country - North America Anti-Tumor Drugs Revenue, (US$, Mn), 2016-2021
Table 27. By Country - North America Anti-Tumor Drugs Revenue, (US$, Mn), 2022-2027
Table 28. By Country - North America Anti-Tumor Drugs Sales, (K Units), 2016-2021
Table 29. By Country - North America Anti-Tumor Drugs Sales, (K Units), 2022-2027
Table 30. By Country - Europe Anti-Tumor Drugs Revenue, (US$, Mn), 2016-2021
Table 31. By Country - Europe Anti-Tumor Drugs Revenue, (US$, Mn), 2022-2027
Table 32. By Country - Europe Anti-Tumor Drugs Sales, (K Units), 2016-2021
Table 33. By Country - Europe Anti-Tumor Drugs Sales, (K Units), 2022-2027
Table 34. By Region - Asia Anti-Tumor Drugs Revenue, (US$, Mn), 2016-2021
Table 35. By Region - Asia Anti-Tumor Drugs Revenue, (US$, Mn), 2022-2027
Table 36. By Region - Asia Anti-Tumor Drugs Sales, (K Units), 2016-2021
Table 37. By Region - Asia Anti-Tumor Drugs Sales, (K Units), 2022-2027
Table 38. By Country - South America Anti-Tumor Drugs Revenue, (US$, Mn), 2016-2021
Table 39. By Country - South America Anti-Tumor Drugs Revenue, (US$, Mn), 2022-2027
Table 40. By Country - South America Anti-Tumor Drugs Sales, (K Units), 2016-2021
Table 41. By Country - South America Anti-Tumor Drugs Sales, (K Units), 2022-2027
Table 42. By Country - Middle East & Africa Anti-Tumor Drugs Revenue, (US$, Mn), 2016-2021
Table 43. By Country - Middle East & Africa Anti-Tumor Drugs Revenue, (US$, Mn), 2022-2027
Table 44. By Country - Middle East & Africa Anti-Tumor Drugs Sales, (K Units), 2016-2021
Table 45. By Country - Middle East & Africa Anti-Tumor Drugs Sales, (K Units), 2022-2027
Table 46. Roche Corporate Summary
Table 47. Roche Anti-Tumor Drugs Product Offerings
Table 48. Roche Anti-Tumor Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 49. Novartis Corporate Summary
Table 50. Novartis Anti-Tumor Drugs Product Offerings
Table 51. Novartis Anti-Tumor Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 52. Celgene Corporate Summary
Table 53. Celgene Anti-Tumor Drugs Product Offerings
Table 54. Celgene Anti-Tumor Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 55. Anti-Tumor Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2019-2021 (K Units)
Table 56. Global Anti-Tumor Drugs Capacity Market Share of Key Manufacturers, 2019-2021
Table 57. Global Anti-Tumor Drugs Production by Region, 2016-2021 (K Units)
Table 58. Global Anti-Tumor Drugs Production by Region, 2022-2027 (K Units)
Table 59. Anti-Tumor Drugs Market Opportunities & Trends in Global Market
Table 60. Anti-Tumor Drugs Market Drivers in Global Market
Table 61. Anti-Tumor Drugs Market Restraints in Global Market
Table 62. Anti-Tumor Drugs Raw Materials
Table 63. Anti-Tumor Drugs Raw Materials Suppliers in Global Market
Table 64. Typical Anti-Tumor Drugs Downstream
Table 65. Anti-Tumor Drugs Downstream Clients in Global Market
Table 66. Anti-Tumor Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Anti-Tumor Drugs Segment by Type
Figure 2. Anti-Tumor Drugs Segment by Application
Figure 3. Global Anti-Tumor Drugs Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Anti-Tumor Drugs Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Anti-Tumor Drugs Revenue, 2016-2027 (US$, Mn)
Figure 7. Anti-Tumor Drugs Sales in Global Market: 2016-2027 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Anti-Tumor Drugs Revenue in 2020
Figure 9. By Type - Global Anti-Tumor Drugs Sales Market Share, 2016-2027
Figure 10. By Type - Global Anti-Tumor Drugs Revenue Market Share, 2016-2027
Figure 11. By Type - Global Anti-Tumor Drugs Price (USD/Unit), 2016-2027
Figure 12. By Application - Global Anti-Tumor Drugs Sales Market Share, 2016-2027
Figure 13. By Application - Global Anti-Tumor Drugs Revenue Market Share, 2016-2027
Figure 14. By Application - Global Anti-Tumor Drugs Price (USD/Unit), 2016-2027
Figure 15. By Region - Global Anti-Tumor Drugs Sales Market Share, 2016-2027
Figure 16. By Region - Global Anti-Tumor Drugs Revenue Market Share, 2016-2027
Figure 17. By Country - North America Anti-Tumor Drugs Revenue Market Share, 2016-2027
Figure 18. By Country - North America Anti-Tumor Drugs Sales Market Share, 2016-2027
Figure 19. US Anti-Tumor Drugs Revenue, (US$, Mn), 2016-2027
Figure 20. Canada Anti-Tumor Drugs Revenue, (US$, Mn), 2016-2027
Figure 21. Mexico Anti-Tumor Drugs Revenue, (US$, Mn), 2016-2027
Figure 22. By Country - Europe Anti-Tumor Drugs Revenue Market Share, 2016-2027
Figure 23. By Country - Europe Anti-Tumor Drugs Sales Market Share, 2016-2027
Figure 24. Germany Anti-Tumor Drugs Revenue, (US$, Mn), 2016-2027
Figure 25. France Anti-Tumor Drugs Revenue, (US$, Mn), 2016-2027
Figure 26. U.K. Anti-Tumor Drugs Revenue, (US$, Mn), 2016-2027
Figure 27. Italy Anti-Tumor Drugs Revenue, (US$, Mn), 2016-2027
Figure 28. Russia Anti-Tumor Drugs Revenue, (US$, Mn), 2016-2027
Figure 29. Nordic Countries Anti-Tumor Drugs Revenue, (US$, Mn), 2016-2027
Figure 30. Benelux Anti-Tumor Drugs Revenue, (US$, Mn), 2016-2027
Figure 31. By Region - Asia Anti-Tumor Drugs Revenue Market Share, 2016-2027
Figure 32. By Region - Asia Anti-Tumor Drugs Sales Market Share, 2016-2027
Figure 33. China Anti-Tumor Drugs Revenue, (US$, Mn), 2016-2027
Figure 34. Japan Anti-Tumor Drugs Revenue, (US$, Mn), 2016-2027
Figure 35. South Korea Anti-Tumor Drugs Revenue, (US$, Mn), 2016-2027
Figure 36. Southeast Asia Anti-Tumor Drugs Revenue, (US$, Mn), 2016-2027
Figure 37. India Anti-Tumor Drugs Revenue, (US$, Mn), 2016-2027
Figure 38. By Country - South America Anti-Tumor Drugs Revenue Market Share, 2016-2027
Figure 39. By Country - South America Anti-Tumor Drugs Sales Market Share, 2016-2027
Figure 40. Brazil Anti-Tumor Drugs Revenue, (US$, Mn), 2016-2027
Figure 41. Argentina Anti-Tumor Drugs Revenue, (US$, Mn), 2016-2027
Figure 42. By Country - Middle East & Africa Anti-Tumor Drugs Revenue Market Share, 2016-2027
Figure 43. By Country - Middle East & Africa Anti-Tumor Drugs Sales Market Share, 2016-2027
Figure 44. Turkey Anti-Tumor Drugs Revenue, (US$, Mn), 2016-2027
Figure 45. Israel Anti-Tumor Drugs Revenue, (US$, Mn), 2016-2027
Figure 46. Saudi Arabia Anti-Tumor Drugs Revenue, (US$, Mn), 2016-2027
Figure 47. UAE Anti-Tumor Drugs Revenue, (US$, Mn), 2016-2027
Figure 48. Global Anti-Tumor Drugs Production Capacity (K Units), 2016-2027
Figure 49. The Percentage of Production Anti-Tumor Drugs by Region, 2020 VS 2027
Figure 50. Anti-Tumor Drugs Industry Value Chain
Figure 51. Marketing Channels

Roche
Novartis
Celgene